Abstract:Abstract Abstract 1836 Clioquinol (5-chloro-7-iodo-8-hydroxyquinoline, CQ) is an old and effective antifungal and amoebicidal drug but is restricted or discontinued in some countries because of its suspect causality in inducing subacute myelo-optic neuropathy, however it has been recently revitalized as an anti-cancer drug candidate at both in vitro and in vivo models. Our previous study suggested that CQ induced cell death and displayed anti-leukemia and anti-myeloma activity (Mao × et al, Leukemia, 2009), but its mechanisms are not well known. In this study, we demonstrated that clioquinol-induced cell death is via intrinsic rather than extrinsic apoptotic pathway, clioquinol-induced apoptosis depends on the activation of caspase-9 and -3. Because zinc is essential for the enzymatic activity of histone deacetylases (HDAC) which is currently emerging as a novel target for apoptotis and cancer treatment, and clioquinol is a strong chelator of zinc ion, we questioned whether clioquinol could interfere with HDAC activity by binding to zinc. Thus, we first examined the effects of clioquinol on the most often used hallmarks for HDAC inhibitions, including cyclin D, p21(CIP1), and p27(KIP1) (Nature Reviews Cancer, 2006). DNA microarray analysis indicated that clioquinol and its analogs significantly up-regulated the transcriptional level of p21 > 2–10 folds within 24 hr. The increased expression of p21(CIP1) protein was further confirmed by western blotting assay in various cell lines and primary patient samples. Clioquinol induced p21(CIP1) expression at concentrations as low as 5 μM witin 24 hr. At the same concentration, tumor suppressor and cell cycle regulator p27 (KIP1) was also increased. In addition, clioquinol also down-regulated expression of D-cyclins, including cyclin D2 and D3 in tested cell lines at a concentration consistent with that induced cell apoptosis. All these changes by clioquinol resulted in cell cycle arrest at G0/G1 phase in both leukemia and myeloma cell lines. Because these genes (cyclin D, p21 and p27) are most associated with histone acetylases, we next checked whether clioquinol is effective in inhibiting HDAC activity. Both leukemia and myeloma cell lines and primary patient samples were applied for the analysis of acetylation status of histone 3 (Ac-H3). Using trichostatin A (TSA) as a positive control, we found that clioquinol accumulated Ac-H3 in all tested cell lines and primary patient samples in a concentration- and time-dependent manner, which strongly suggested that clioquinol interfere with HDAC activity. Subsequently, we analyzed the interaction of clioquinol and HDAC. Just like TSA, clioquinol was docked into the active pocket of HDAC, where clioquinol competitively binds to zinc at the active center, which was confirmed by zinc addition. Zinc addition partially abolished the effects of clioquinol on HDAC activity. Thus, our study indicated that clioquinol-induced cell death in both leukemia and myeloma was via an apoptotic pathway by interfering with HDAC activity. Disclosures: No relevant conflicts of interest to declare.

Induction of Cell Cycle Arrest Via the P21, P27–cyclin E,A/Cdk2 Pathway in SMMC-7721 Hepatoma Cells by Clioquinol

Induction of cell cycle arrest via the p 21 , p 27 – cyclin E , A / Cdk 2 pathway in SMMC-7721 hepatoma cells

Schisandrin B inhibits cell proliferation and induces apoptosis in human cholangiocarcinoma cells.

Clioquinol induces S-phase cell cycle arrest through the elevation of the calcium level in human neurotypic SH-SY5Y cells

Clioquinol Inhibits Cell Growth in a SERCA2-dependent Manner

Clioquinol Arrests Cell Cycle At G1 Phase And Triggers Intrinsic Apoptosis In Myeloma And Leukemia Cells By Inhibiting Histone Deacetylases

The Antiparasitic Clioquinol Induces Apoptosis in Leukemia and Myeloma Cells by Inhibiting Histone Deacetylase Activity*

Quercetin induces cell cycle G1 arrest through elevating Cdk inhibitors p21 and p27 in human hepatoma cell line (HepG2).

Clioquinol Induces G2/M Cell Cycle Arrest Through the Up-Regulation of TDH3 in Saccharomyces Cerevisiae.

Induction of cell cycle arrest by the carbazole alkaloid Clauszoline-I from Clausena vestita D. D. Tao via inhibition of the PKCδ phosphorylation.

Thymoquinone Induces G2/M Arrest, Inactivates PI3K/Akt and Nuclear Factor-Κb Pathways in Human Cholangiocarcinomas Both in Vitro and in Vivo.

Radiosensitization of Clioquinol and Zinc in Human Cancer Cell Lines.

Chaetominine induces cell cycle arrest in human leukemia K562 and colon cancer SW1116 cells

Quercetin reduces cyclin D1 activity and induces G1 phase arrest in HepG2 cells.

Clioquinol Induces Pro-Death Autophagy in Leukemia and Myeloma Cells by Disrupting the Mtor Signaling Pathway

Induction of Apoptosis and Cell Cycle Arrest in Human Hcc Mhcc97h Cells with Chrysanthemum Indicum Extract

Clioquinol targets zinc to lysosomes in human cancer cells.

Effects of Tachyplesin on the Regulation of Cell Cycle in Human Hepatocarcinoma SMMC-7721 Cells

SKLB70326, a Novel Small-Molecule Inhibitor of Cell-Cycle Progression, Induces G0/G1 Phase Arrest and Apoptosis in Human Hepatic Carcinoma Cells

The Quinazoline Derivative, 04NB-03, Induces Cell Cycle Arrest and Apoptosis in Hepatocellular Carcinoma Cells in a Reactive Oxygen Species-Dependent Manner.

2-(3-Fluorophenyl)-6-methoxyl-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid (YJC-1) Induces Mitotic Phase Arrest in A549 Cells